Considering the importance of a correct cellular localization of key proteins, as described for XPO1, IPO1 may play a major role in the physiopathology of cHL, opening new perspectives for the treatment of refractory/relapsed cHL patients. Here, XPO1 is linked to classic Hodgkin lymphoma.